Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.
货号（Catalog No.）
CSD00151
通用名INN
Etaracizumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
生物活性
产品描述(Description)
Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.
别名(Alternative names)
MEDI-522,hLM60
靶点;物种(Specificity target name;species)
ITGAV_ITGB3[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG1-nd
化学信息
CAS
892553-42-3
存储条件(Storage)
store at -80°C